EHAB
HealthcareEnhabit, Inc. · Medical - Care Facilities · $710M
What is Enhabit, Inc.?
Enhabit, Inc. is a US-based provider of home health and hospice services, operating across 34 states. Spun off as a standalone company in mid-2022, it serves patients who need clinical care and end-of-life support in home settings.
Enhabit generates revenue by delivering skilled nursing, therapy, and chronic disease management through its home health agencies, alongside hospice services for terminally ill patients and their families. Clinicians provide wound care, cardiac rehabilitation, infusion therapy, and disease-specific programs. Hospice teams address pain management, palliative counseling, and bereavement support. The company contracts with Medicare, Medicaid, and private insurers to fund these services.
Enhabit was incorporated in 2014 and is headquartered in Dallas, Texas, operating independently since July 2022.
- Home health nursing and chronic disease management
- Physical, occupational, and speech therapy services
- Hospice pain management and palliative care
- Bereavement and spiritual counseling for families
Is EHAB a Good Stock to Buy?
UQS Score rates EHAB as Below Average overall, reflecting meaningful challenges across several key dimensions.
The Valuation pillar stands out as the relative bright spot, rated Good — suggesting the market may already be pricing in the company's difficulties. The Growth pillar registers as Neutral, indicating neither a clear expansion story nor a sharp contraction.
Quality, Moat, and Risk all carry Weak ratings, pointing to thin competitive insulation, profitability pressures, and elevated financial or operational risk.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does EHAB pay dividends?
No — Enhabit, Inc. does not currently pay a dividend.
Enhabit does not currently pay a dividend. As a relatively young standalone company still working to strengthen its financial footing, capital is directed toward operational priorities rather than shareholder distributions. Income-focused investors should note the absence of a dividend program at this stage.
When does EHAB report earnings?
Enhabit reports earnings on a quarterly cadence, consistent with standard US-listed equity practice.
The company's recent results reflect the operational pressures visible in its UQS pillar profile — particularly around quality and risk. Revenue trends have been shaped by reimbursement dynamics and staffing conditions common across the home health sector.
For the most recent quarter's results and guidance, visit Enhabit's investor relations page directly.
EHAB Price History
-40.3% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Enhabit, Inc.?
Based on Enhabit, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
EHAB Long-term Outlook
Enhabit's fundamental outlook is shaped by a Neutral Growth profile alongside Weak Quality and Risk ratings. The home health and hospice sector benefits from long-term demographic tailwinds as the US population ages, but Enhabit faces near-term headwinds from reimbursement pressures and cost management challenges. A Good Valuation rating suggests downside may be partially reflected in the current price, though structural risks remain.
Growth drivers
- Aging US population increasing demand for home-based care
- Potential operational improvements as the company matures post-spinoff
- Expansion of hospice agency footprint across existing states
Key risks
- Medicare and Medicaid reimbursement rate changes
- Ongoing staffing and labor cost pressures in home health
- Weak moat leaving the business exposed to competitive pricing
EHAB vs Peers
Enhabit operates in a fragmented healthcare services landscape alongside companies that address adjacent patient care and workforce needs.
COMPASS Pathways focuses on mental health treatment research rather than home-based care, representing a distinct clinical and business model from Enhabit's service delivery approach.
Sonida operates senior living communities, serving an overlapping elderly demographic but through facility-based residential care rather than in-home clinical services.
AMN Healthcare provides healthcare workforce solutions and staffing — a critical upstream input for companies like Enhabit that depend on skilled clinical labor.
Frequently Asked Questions
What does Enhabit do?
Enhabit provides home health and hospice services across 34 US states. Its home health division delivers skilled nursing, therapy, and chronic disease management in patients' homes. Its hospice division supports terminally ill patients and their families with pain management, palliative care, and bereavement counseling.
Does EHAB pay dividends?
No, Enhabit does not currently pay a dividend. The company is focused on operational priorities as a relatively young standalone business. Investors seeking regular income should factor this into their assessment of EHAB.
When does EHAB report earnings?
Enhabit follows a standard quarterly earnings cadence for US-listed companies. Specific upcoming dates are not covered by our data source — check Enhabit's investor relations page for the current reporting schedule.
Is EHAB a good stock to buy?
UQS Score rates EHAB as Below Average, driven by Weak ratings across Quality, Moat, and Risk pillars. The Valuation pillar is rated Good, which may reflect existing market pessimism. Investors should review the full pillar breakdown before drawing conclusions.
Is EHAB overvalued?
Based on the UQS Valuation pillar, EHAB is rated Good — meaning the stock does not appear expensive relative to its fundamentals at current levels. However, a favorable valuation alone does not offset the Weak ratings seen in other pillars.
How does EHAB compare to its competitors?
Enhabit operates in a distinct niche within healthcare services. Compared to peers like Sonida Senior Living and AMN Healthcare, Enhabit is more narrowly focused on home-based clinical care and hospice. Its UQS profile currently lags stronger-rated healthcare peers on quality and moat dimensions.
What is EHAB's market cap bracket?
Enhabit is classified as a small-cap company. This places it in a segment of the market that can carry higher volatility and liquidity risk compared to large- or mega-cap healthcare peers.
Who founded Enhabit?
Enhabit was incorporated in 2014 as a subsidiary of Encompass Health, operating under the name Encompass Health Home Health Holdings, Inc. It rebranded as Enhabit, Inc. in March 2022 and became an independent publicly traded company in July 2022.
Is EHAB a long-term quality investment?
As a long-term quality indicator, EHAB's UQS profile presents concerns. Weak scores in Quality, Moat, and Risk suggest the business lacks the durable competitive advantages and financial resilience typically associated with strong long-term holdings. The full analysis is available to Pro members.
What sector does EHAB belong to?
Enhabit operates in the Healthcare sector, specifically within home health and hospice services. This segment is influenced by Medicare and Medicaid reimbursement policy, an aging US population, and labor market conditions for clinical staff.
Unlock Full EHAB Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar ratings for EHAB
- ✓Access detailed financial metrics behind the Quality and Risk assessments
- ✓Compare EHAB side-by-side with competitors using UQS pillar data
- ✓Screen for stronger-rated healthcare stocks using UQS filters
- ✓Get the complete analyst view available exclusively to Pro members
Pro Analysis
EHAB — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | 44.5 | 37.4 | 24.0 | 46.0 | 59.0 | 74.3 | +4.9 |
| May 7, 2026 | 39.6 | 36.7 | 24.0 | 46.4 | 26.4 | 74.5 | +0.2 |
| May 1, 2026 | 39.4 | 36.7 | 24.0 | 46.4 | 26.4 | 73.1 | +0.3 |
| Apr 26, 2026 | 39.1 | 36.7 | 24.0 | 46.4 | 26.4 | 71.2 | -0.1 |
| Apr 24, 2026 | 39.2 | 36.7 | 24.0 | 46.4 | 26.4 | 72.3 | +0.1 |
| Apr 23, 2026 | 39.1 | 36.7 | 24.0 | 46.4 | 26.4 | 71.3 | -0.1 |
| Apr 20, 2026 | 39.2 | 36.7 | 24.0 | 46.4 | 26.4 | 71.8 | 0.0 |
| Apr 19, 2026 | 39.2 | 36.7 | 24.0 | 46.4 | 26.4 | 71.9 | +0.1 |
| Apr 18, 2026 | 39.1 | 36.7 | 24.0 | 46.4 | 26.4 | 71.5 | -1.2 |
| Apr 15, 2026 | 40.3 | 36.7 | 24.0 | 46.4 | 26.4 | 79.6 | -0.1 |
EHAB — Pillar Breakdown
Quality
— 37.4/100 (25%)Enhabit, Inc. has average quality metrics, with room for improvement in margins or capital efficiency.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 46.5/100 (20%)Enhabit, Inc. shows steady but unspectacular growth, typical for mature companies.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 27.2/100 (15%)Enhabit, Inc. presents elevated risk with concerns around leverage or financial stability.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 64.5/100 (15%)Enhabit, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 24/100 (25%)Enhabit, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for EHAB.
Score Composition
Financial Data
More Stock Analysis
How is the EHAB UQS Score Calculated?
The UQS (Unified Quality Score) for Enhabit, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Enhabit, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Enhabit, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.